Elevated arginine vasopressin levels in squamous cell cancer of the head and neck

Laryngoscope

Volumn 106, Issue 3, 1996, Pages 317-321

  Talmi, Yoav P ^a   Wolf, Gregory T ^b   Hoffman, Henry T ^c   Krause, Charles J ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VASOPRESSIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0029965306     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199603000-00014     Document Type: Article

References (34)

1. Veltri RW, Maxim PE. Tumor immunity and tumor markers in head and neck cancer. In: Wolf GT, ed. Head and Neck Oncology. Boston: Martinus Nijhoff Publishers, 1984.
2. Goodwin WJ Jr., Kirchner JC, Sasaki CT. Plasma tumor markers associated with squamous carcinoma of the upper aerodigestive tract. In: Wolf GT, Carey TE, eds. Head and Neck Oncology Research. Amsterdam: Kugler and Ghedini, 1988.
3. Bhatavdekar JM, Vora HH, Patel DD. Serum sialic acid forms as markers for head and neck malignancies. Neoplasma. 1988;35:425-434.
4. Eibling DE, Johnson JT, Wagner RL. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope. 1989;99:117-124.
5. Fischbach W, Meyer T, Barthel K. Squamous cell carcinoma antigen in the diagnosis and treatment follow up of oral and facial squamous cell carcinoma. Cancer. 1990;65:1321-1324.
6. Clasen B, Pere P, Senekowitsch R, et al. Squamous cell carcinoma-associated antigen (SCCA) as a tumor marker in the initial diagnosis of carcinomas of the head and neck region. Results of a prospective study after 24 months. Laryngorhinootologie. 1990;69:275-280.
7. Ropka ME, Goodwin WJ, Levine PA, et al. Effective head and neck tumor markers. The continuing quest. Arch Otolaryngol Head Neck Surg. 1991;117:1011-1014.
8. Straka MB, Wagner RL, Johnson JT, et al. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125. Arch Otolaryngol Head Neck Surg. 1992;118:802-805.
9. Dreyfuss A, Clark JR, Anderson JW. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck. Cancer. 1992;70:2499-2503.
10. Walther EK, Dahlmann N, Gorgulla HT. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCCA, TK, and dTTPase. Head Neck. 1993; 15:230-235.
11. Hanna EYN, Papay FA, Gupta MK, et al. Serum tumor markers of head and neck cancer: current status. Head Neck. 1990;12:50-59.
12. Baskies AM, Chretien PB, Maxim PE, et al. Circulating immune complexes correlate with levels of serum immune reactive proteins and clinical tumor stage in head and neck squamous carcinoma. Surg Forum. 1980;31:526-527.
13. Wolf GT, Wolfe RA. Circulating immune complexes in patients with nasopharyngeal carcinoma. Laryngoscope. 1990;100:302-308.
14. Wolf GT, Chretien PB, Elias EG, et al. Serum glycoproteins in head and neck squamous carcinoma. Am J Surg. 1979;138:489-500.
15. Zohar Y, Talmi YP, Finkelstein Y, et al. Syndrome of inappropriate antidiuretic hormone secretion in cancer of the head and neck. Ann Otol Rhinol Laryngol. 1991;100:341-344.
16. Moses AM, Miller M, Streeten DHP. Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism. 1976;25:697-721.
17. Abdi EA, Bishop S. The syndrome of inappropriate antidiuretic hormone secretion with carcinoma of the tongue. Med Pediatr Oncol. 1988;16:210-215.
18. Okutomi T, Sakata S, Tatematsu N, et al. Squamous cell carcinoma of tongue and floor of mouth associated with syndrome of inappropriate secretion of antidiuretic hormone. J Oral Maxillofac Surg. 1987;45:447-449.
19. Hayes DF, Lechan RM, Posner MR, et al. The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell cancer of the head and neck. J Surg Oncol. 1986;32:150-152.
20. Osterman M, Calhoun A, Dunham M. Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma. Arch Intern Med. 1986;146:1731-1735.
21. Kandylis KV, Vasilomanolakis M, Efremides AD. Syndrome of inappropriate antidiuretic hormone secretion in pyriform sinus squamous cell carcinoma. Am J Med. 1986;81:946.
22. Srigley JR, Dayal VS, Gregor RT, et al. Hyponatremia secondary to olfactory neuroblastoma. Arch Otolaryngol Head Neck Surg. 1983;109:559-562.
23. Tatemoto K, Goto K, Uno T, et al. A case of adenocarcinoma of the nasal cavity associated with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Gan No Rinsho. 1989;35:1153-1159.
24. Singh W, Ramage C, Best P, et al. Nasal neuroblastoma secreting vasopressin. Cancer. 1980;45:961-966.
25. Cullen MJ, Cusack DA, O'Briain DS, et al. Neurosecretion of arginine vasopressin by an olfactory neuroblastoma causing reversible syndrome of antidiuresis. Am J Med. 1986;81:911-916.
26. Kavanagh BD, Halperin EC, Rosenbaum LC, et al. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer. 1992;69:1315-1319.
27. Talmi YP, Hoffman HT, McCabe BF. Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol. 1992;101:946-949.
28. Robertson GL, Mahr EA, Athar S, et al. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest. 1973;52:2340-2352.
29. Biran H, Feld R, Sagman U, et al. Carcinoembryonic antigen, arginine vasopressin and calcitonin as markers of early small-cell lung cancer relapse. Tumor Biol. 1989;10:258-267.
30. Baylis PH. Vasopressin and its neurophysin. In: DeGroot LJ, ed. Endocrinology. Philadelphia: WB Saunders, 1989;213-229.
31. Odell WD, Wolfsen AR. Humoral syndromes associated with cancer. Annu Rev Med. 1978;29:379-406.
32. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med. 1980;31:315-327.
33. McQuarrie DG, Mayberg M, Ferguson M, et al. A physiologic approach to the problems of simultaneous bilateral neck dissection. Am J Surg. 1977;134:455-460.
34. Wenig BL, Heller KS. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following neck dissection. Laryngoscope. 1987;97:467-470.